UCB

UCB

United States; England United Kingdom; North Carolina United States; Europe; Northern Europe; Americas; North America
Is it you?
Investor info
Type
Corporate Venture Capital
Stage focus
  • Early stage VC
Industry focus
Description
UCB is a global biopharmaceutical company focused on discovering and developing innovative medicines and solutions for people living with severe diseases in immunology and neurology. They aim to transform the lives of patients through science and expertise.
Previous investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
X Feed
See other investors focused on
Pharmaceuticals
Other investors you may be interested in
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.